APOE and early-onset autosomal dominant Alzheimer disease: The clinical importance of ApoE and its ability to modulate both amyloid formation and disease progression recently gained further support in a case report, showing a strong protective effect of ApoE3 Christchurch variant on the background of an aggressive familial presenilin mutation, expected to result in early-onset Alzheimer’s disease [35].